1
Menu
home
>
News
>
WESAIL Presents Latest POCT Innovations at MEDICA 2022

WESAIL Presents Latest POCT Innovations at MEDICA 2022

  • Categories:News
  • Time of issue:2022-11-18 15:31
  • Views:

WESAIL Presents Latest POCT Innovations at MEDICA 2022

Information

(Nov.17, 2022, Düsseldorf, Germany) Guangdong Wesail Biotech Co., Ltd. (WESAIL) attended this year’s MEDICA trade fair, which was held in Düsseldorf, Germany, from November 14 to 17, 2022.  

 

 

At the show, WESAIL showcased its latest immunofluorescence POCT instruments and reagents, all developed in-house based on the Company’s in-depth research. The instruments on display include the single-channel immunofluorescence analyzer, handheld fluorescent/colloidal gold immunoanalyzer, 6-channel immunofluorescence analyzer, cartridge incubator and the handheld fluorescence analyzer with inbuilt incubator. The five analyzers provide rapid, precise, sensitive and convenient test results. Furthermore, WESAIL presented 30+ immunofluorescence reagents covering 14 disease groups, such as cardiac marker, fertility, inflammation, thyroid, tumor marker, renal function, diabetes, anemia and more.

 

  

 

WESAIL also highlighted two automatic chemiluminescence immunoanalyzers and reagents at the booth. The chemiluminescence immunoanalyzers are rapid, precise, stable, easy-to-use, and efficient, meeting the needs and demands of customers. Adding to this, WESAIL provides chemiluminescence reagents for cardiovascular disease, inflammation and others.

 

 

In addition, WESAIL presented its newly developed monkeypox virus Ag test kit (for professional use only) and hot sale COVID-19 Ag test kits (for self-testing). In response to the monkeypox outbreak, the Company quickly launched its test kit for monkeypox testing and obtained CE marking and the UK MHRA license. Likewise, since the outbreak of the COVID-19 pandemic in early 2020, WESAIL developed colloidal gold test kits for detecting COVID-19, which greatly shortened the diagnosis time. Thanks to its reliable performance, WESAIL’s COVID-19 Ag test kit was the 4th to be certified with TÜV SÜD CE0123. Over the last couple of years, WESAIL has distributed COVID-19 Ag test kits around the world to support the fight against the pandemic.

 

  

 

By providing more rapid, precise, sensitive, convenient and extensive diagnostic products to patients, WESAIL continues to maintain a leading position among players in the global POCT industry, making point-of-care testing as accessible as possible.

 

Vincent Nong, international sales director, said: “We are delighted to introduce our innovative POCT analyzers and reagents at MEDICA 2022. WESAIL is a young, yet fast growing brand. We strive to continuously meet the needs and demands of our customers, by developing products and technologies that can deliver results quickly, accurately and efficiently. At WESAIL, we believe that accessibility is key and we hope to further make our broad range of medical diagnostics products and technologies accessible to all.

Previous: None
Next: WESAIL COVID-19 Ag Test Kit Experimentally Proved to Be Effective on Omicron Live Virus
Previous: None
Next: WESAIL COVID-19 Ag Test Kit Experimentally Proved to Be Effective on Omicron Live Virus
top

Address：Room 403, Building 1, 1 Taoyuan RD, Songshan Lake Science and Technology Industrial Park, Songshan Lake, Dongguan, Guangdong, 523808, China
TEL:   +86-769-22890969
E-mail：customer@wesailbio.com

这是描述信息

Address：Room 403, Building 1, 1 Taoyuan RD, Songshan Lake Science and Technology Industrial Park, Songshan Lake, Dongguan, Guangdong, 523808, China
TEL:   +86-769-22890969
E-mail： customer@wesailbio.com

验证码